South Africa Ai-Based Clinical Trials Solution Provider Market
The ai-based clinical trials solution provider market in South Africa is expected to reach a projected revenue of US$ 134.8 million by 2030. A compound annual growth rate of 22.3% is expected of South Africa ai-based clinical trials solution provider market from 2022 to 2030.
South Africa ai-based clinical trials solution provider market highlights
The South Africa ai-based clinical trials solution provider market generated a revenue of USD 22.0 million in 2021 and is expected to reach USD 134.8 million by 2030.
The South Africa market is expected to grow at a CAGR of 22.3% from 2022 to 2030.
In terms of segment, oncology was the largest revenue generating therapeutic applications in 2021.
CVD is the most lucrative therapeutic applications segment registering the fastest growth during the forecast period.
Ai-based clinical trials solution provider market data book summary
Market revenue in 2021
USD 22.0 million
Market revenue in 2030
USD 134.8 million
Growth rate
22.3% (CAGR from 2021 to 2030)
Largest segment
Oncology
Fastest growing segment
CVD
Historical data
2018 - 2020
Base year
2021
Forecast period
2022 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases
Key market players worldwide
The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR
Other key industry trends
In terms of revenue, South Africa accounted for 1.7% of the global ai-based clinical trials solution provider market in 2021.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Middle East & Africa, South Africa ai-based clinical trials solution provider market is projected to lead the regional market in terms of revenue in 2030.
UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 47.6 million by 2030.
The South Africa AI-based clinical trials solution providers market is expected to witness growth owing to presence of well-established infrastructure, diverse population, easy availability of experts, formation of separate drug regulatory agency, and easy patient recruitment.
In order to accelerate drug registration process, a new drug regulatory agency named South African Health Products Regulatory Authority (SAHPRA) was established in August 2013. These factors are anticipated to increase the adoption of technologically advanced solutions for management of clinical trials.
In addition, presence of global companies in the country that provide advanced solutions for ongoing as well as other clinical research is fueling market growth. For instance, Medidata, a global company providing AI-based clinical trial management platform, has presence in the country through worldwide product sales and support.
South Africa artificial intelligence based clinical trials solution provider market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to AI-based Clinical Trials Solution Provider Market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.64% in 2021.
Horizon Databook has segmented the South Africa ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
The South Africa AI-based clinical trials solution providers market is expected to witness growth owing to presence of well-established infrastructure, diverse population, easy availability of experts, formation of separate drug regulatory agency, and easy patient recruitment.
In order to accelerate drug registration process, a new drug regulatory agency named South African Health Products Regulatory Authority (SAHPRA) was established in August 2013. These factors are anticipated to increase the adoption of technologically advanced solutions for management of clinical trials.
In addition, presence of global companies in the country that provide advanced solutions for ongoing as well as other clinical research is fueling market growth. For instance, Medidata, a global company providing AI-based clinical trial management platform, has presence in the country through worldwide product sales and support.
South Africa Ai-Based Clinical Trials Solution Provider Market Therapeutic Applications Outlook (Revenue, USD Million , 2018-2030)
Oncology
CVD
Neurological Diseases or conditions
Metabolic diseases
Infectious diseases
Others
South Africa Ai-Based Clinical Trials Solution Provider Market Clinical Trial Phase Outlook (Revenue, USD Million , 2018-2030)
Phase-I
Phase-II
Phase-III
South Africa Ai-Based Clinical Trials Solution Provider Market End User Outlook (Revenue, USD Million , 2018-2030)
Pharmaceutical Companies
Academia
Others
Reasons to subscribe to artificial intelligence based clinical trials solution provider market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of artificial intelligence based clinical trials solution provider market databook
Our clientele includes a mix of artificial intelligence based clinical trials solution provider market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa artificial intelligence based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into South Africa artificial intelligence based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
South Africa Ai-Based Clinical Trials Solution Provider Market, 2018-2030 (US$M)